-
-
Roger Mallol Parera
Board Member (Co-founder)
(Gratallops, 1981) has a PhD in Bioengineering from the URV (2014), graduated in Computer Engineering from the Universitat Autònoma de Barcelona (2008), completed his master’s degree in Electronics at the URV (2009) and a postgraduate qualification at the Universitat Oberta de Catalunya (2012). Roger Mallol is a member of the founding partners and the Management Board of Biosfer Teslab, where he has worked as CEO (2014-2015). Currently he is a Postdoctoral researcher in the University of Lausana. In addition, he has worked as a researcher at the Pere Virgili Institute for Health Research (2012-2013), had a doctoral visit at the University of Manchester (2011) and worked at the multinational Lionbridge during his Erasmus stay in Finland (2007-2008).
-
-
Núria Amigó Grau
President and CEO (Scientific management and Co-founder)
(Reus, 1984) Graduated in Physics from the University of Barcelona (2009), where she also completed a master’s degree in Biophysics (2010) and has a PhD in Biomedial engineering at the URV. She has carried out research at the Science Park of Barcelona and the Platform of X-Ray Diffraction Crystallography, and she has worked as a research collaborator in Biophysics and Neural Networks at the University of Barcelona (2009-2010) during which time she visited as a researcher the Weizmann Institute of Science (Rehovot, Israel) in the Department of Physics of Complex Systems. She has recently finished a doctoral stage as a research trainee at the Brigham and Women’s Hospital / Harvard Medical School (Boston, USA).
-
-
Xavier Correig Blanchar
Scientific advisor and co-founder
(Reus, 1960) has a PhD in Telecommunications Engineering from the Universitat Politècnica de Catalunya (1988) and is currently a professor at the Universitat Rovira i Virgili in the Department of Electronic Engineering. Between 1999 and 2001 he directed theCIDEM’s Centre for Innovation in Electronic Engineering, and between 2002 and 2006 he was the URV’s vice-rector for Innovation and Transfer. In 2007 he created the Metabolomics Platform, a scientific infrastructure belonging to the Networking Biomedical Research Centre in Diabetes and Associated Metabolic Diseases, currently part of the URV’s Centre for Omic Sciences. He has been on postdoctoral visits to the Automotive Development Center (Lear Corp., 1999) and the London Center for Nanotechnologies (London, 2007). His research interest focuses on creating nano- and biotechnologies that can be used in biomedicine.
-
-
Lluís Masana Marín
Clinical advisor and co-founder
After graduating in Medicine (1976) and obtaining his PhD in Medicine (1980) from the Universitat Autònoma de Barcelona, he had a postdoctoral visit at the Department of Chemical Pathology of Saint Thomas’s Hospital, London (1983-1984) where he focused on disorders of the lipid metabolism. He has been head of medicine at the Universitat Rovira i Virgili since 1991. Between 1992 and 2006 he was head of the Service of Internal Medicine of the Sant Joan University Hospital in Reus. He has been the director of the Unit of Lipids since 1985 and of the Unit of Vascular Medicine and Metabolism since 2006. Between 2000 and 2004 he was president of the Spanish Arteriosclerosis Society, between 1990 and 1994 a member of the executive committee of the European Lipoprotein Club, and between 2009 and 2012 a member of the executive committee of the European Arteriosclerosis Society.
-
-
Alberico L. Catapano
Clinical Advisor
Born in Milan in 1952. Graduated from the University of Milan (1975) and in 1975 was awarded a specialized qualification in Pharmacology. He has been involved in the field of arteriosclerosis, lipids, lipoproteins and genetic dyslipidemias since 1972. He is a lecturer in Pharmacology at the University of Milan, the director of the lipoprotein and arteriosclerosis laboratory at the Centre for the Study of Arteriosclerosis of the Italian Arteriosclerosis Society at the Basini Hospital, and director of the Centre of Epidemiology and Preventive Pharmacology of the University of Milan. Professor Catapano is the president of the European Arteriosclerosis Society and president of the EAS/ESC guidelines for treating dyslipidaemias. He is a member of the board of several scientific societies, including the Italian Society for the Study of Arteriosclerosis, president of SITEC and director general of the SISA Foundation.
-
-
Baltasar Parra Monclús
Marketing Advisor
Graduated in Medicine and Surgery from the University of Barcelona and holds a master’s degree in marketing management from EADA. He has done courses on strategic sales management and analysis, the development of management skills, management in multinational environments and the development of effective coaching skills. During his professional career in the hospital sector he has held the posts of marketing director at Waldemar Link España, a multinational company specialising in orthopaedic surgery, and general sales director for General Electric Healthcare in its Image Diagnosis Division.
-
-
Daniel Rodriguez Romeu
Software Developer and IT Technician
(Tarragona, 1991) graduated in Computer Engineering by the University Rovira and Virgili, now in the last year of a Master in Intelligent Systems and Computer Securtiy by the same university. Software Developer in different programming languages, interpreted or compiled.
-
-
Miriam Gil Serret
COO
(Arens de Lledó, 1994) graduated in Biotechnology by the University Rovira and Virgili (2016), Honours Degree. She has taken part in an ERASMUS programme in Göteborg University, Sweden (2014-2015). She has done an internship stay in the Biomedical Unit of Research, Reus (2014).
-
-
Sara Samino Gené
Project Manager
(Tarragona, 1987), has a Phd in Biochemistry by Universitat Rovira i Virgili (2013), Graduated in Biotechnology (2009), Master in Nutrition and metabolism (2010) and Master in Integrated Management: quality, environment and occupational health and safety (2018) by the same University. She also did a Postgraduate in Advanced techniques in Applied Statistics (2010) by Universidad Nacional de Educación a Distancia. She had a doctoral stage in ETH in Zurich. She worked as a researcher in CIBERDEM (2013-2015) for Universitat Rovira i Virgili and as a Research Assistant in Universitat Rovira i Virgili (2016-2017).
-
-
Enrique Ozcariz García
I+D Researcher
(Vitoria-Gasteiz, 1995) graduated in Biochemistry and Molecular Biology and Biotechnology by Universitat Rovira i Virgili (2018). He has done an internship stay in Achucarro Basque Center of Neuroscience (2015).